ArticleExperimental hematology & oncology2018

Correlation of plasma concentration and adverse effects of bosutinib: standard dose or dose-escalation regimens of bosutinib treatment for patients with chronic myeloid leukemia.

Akiko Mita et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.